Silence Therapeutics plc Segment Reporting Other Item Amount
Silence Therapeutics plc (SLNCF) reported Segment Reporting Other Item Amount of $3.38 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2025-08-07
- Silence Therapeutics plc segment reporting other item amount for the quarter ending 2025-06-30 was $3.38M.
- Silence Therapeutics plc segment reporting other item amount for the quarter ending 2025-03-31 was $121.00K.
- Silence Therapeutics plc segment reporting other item amount for the quarter ending 2024-06-30 was -$3.86M.
- Silence Therapeutics plc segment reporting other item amount for the quarter ending 2024-03-31 was -$3.51M.
- Silence Therapeutics plc segment reporting other item amount for fiscal 2024 was -$18.86M.
- Silence Therapeutics plc segment reporting other item amount for fiscal 2023 was -$11.11M.
- Silence Therapeutics plc segment reporting other item amount for fiscal 2022 was -$11.39M.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 12 month |
|---|---|---|---|
| 2025-06-30 | $3.38M 10-Q · filed 2025-08-07 | $3.50M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $121.00K 10-Q · filed 2025-05-08 | ||
| 2024-12-31 | -$18.86M 10-K · filed 2025-02-27 | ||
| 2024-06-30 | -$3.86M 10-Q · filed 2025-08-07 | -$7.37M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | -$3.51M 10-Q · filed 2025-05-08 | ||
| 2023-12-31 | -$11.11M 10-K · filed 2025-02-27 | ||
| 2022-12-31 | -$11.39M 10-K · filed 2025-02-27 |